Substituted tricyclic compounds with activity towards ep1 receptors
申请人:Almirall, S.A.
公开号:EP2647638A1
公开(公告)日:2013-10-09
The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.
[EN] SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS<br/>[FR] COMPOSÉS TRICYCLIQUES SUBSTITUÉS POSSÉDANT UNE ACTIVITÉ CONTRE LES RÉCEPTEURS EP1
申请人:ALMIRALL SA
公开号:WO2013149996A9
公开(公告)日:2014-02-20
Niño, Patricia; Caba, Marta; Aguilar, Nuria, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2016, vol. 55B, # 11, p. 1384 - 1399